The Tragic 13‑Year Journey of Tanvi Pariyani at AIIMS

Tanvi Pariyani was barely two when doctors at AIIMS first told her parents she had a ventricular septal defect coupled with pulmonary atresia – a mouthful, I know, but essentially a heart that couldn’t pump blood to her lungs the normal way.

In October 2012 the hospital’s records show the initial scan, and the family was thrust into a world of cat‑scans, angiograms and endless consultations. The next year, a flurry of CT‑angiographies and cardiac catheterisations tried to map out the tangled arteries that fed her lungs. The hope? That surgeons could eventually stitch things back together.

January 31 2014 brought a turning point: an AIIMS estimate certificate that listed a “unifocalisation & conduit” procedure and quoted a cost of roughly ₹1.2‑₹1.25 lakh. For the Pariyanis, that was the first concrete sign that surgery was on the table. They remember being given tentative dates – September 2015, then shifted to November.

But the operation never happened. By mid‑2015 the scheduled date slipped, and by 2016 the family lodged a grievance. The case landed on the desk of Dr. Sachin Talwar, a cardiothoracic surgeon who later told the press that the arteries supplying Tanvi’s lungs were essentially absent – making corrective surgery a dangerous gamble.

Fast‑forward to 2017‑18. AIIMS formally announced that after “detailed evaluation” the team concluded the defect was too complex for repair. The hospital’s narrative says they opted for medical management and regular follow‑up, while Tanvi’s father, Mukesh Pariyani, insisted the girl was still waiting for a surgeon willing to take on her case.

Years slipped by. By June 2025 the family’s grievance resurfaced, pleading that they could not afford treatment elsewhere and still clung to the hope of surgery. AIIMS maintained that senior cardiac surgeons continued to advise against an operation, favouring medical therapy.

In February 2026 the desperation grew louder. Mukesh wrote to the Prime Minister’s Office, saying previous complaints had fallen on deaf ears and Tanvi’s health was deteriorating rapidly.

August 24 2026, Tanvi was admitted again – this time not for a routine fix but as a possible candidate for a heart‑lung transplant, the only option left for her advanced disease. Doctors ran a new battery of tests, hoping to gauge whether a transplant could buy her a few more years.

Tragically, on the early hours of September 1, 2026, Tanvi’s oxygen levels plunged to a frightening 48 %. Despite aggressive oxygen support and resuscitation attempts, she suffered a hypoxic spell followed by cardiac arrest. She was pronounced dead at 5:06 am, just 15 years after that first diagnosis.

The next day AIIMS announced an internal inquiry, assembling a committee to pore over her medical records, imaging, specialist opinions and the autopsy findings. The probe aims to pinpoint when the decision against surgery was taken, the medical reasoning behind it, and how (or if) the family was informed.

Tanvi’s story is now a painful reminder of the thin line between hope and heartbreak in complex congenital heart disease, and it raises uncomfortable questions about accessibility, transparency and accountability in public healthcare.